TRIP

Welcome to the Brand page for “TRIP”, which is offered here for Scientific and technological research and development services, providing biological and pharmaceutical research and development relating to biopharmaceuticals, biologics, and rna molecules and molecular aggregates, and preparations thereof, for the regulation, modulation, expression, and inactivation of individual mammalian and human genes used for diagnosis, treatment, and gene-targeted therapy of human and veterinary diseases and for molecular and pharmaceutical research and development and scientific research of mammalian and human diseases;.

Its status is currently believed to be active. Its class is unavailable. “TRIP” is believed to be currently owned by “Cequent Pharmaceuticals, Inc.”